Tag Archives: regn

5 Top Medical Stocks Reporting Earnings This Week

Before Wall Street escapes for summer vacation, makers of drugs and medical devices are greeting August with a frantic week of earnings reports. Here are five of the leading stocks reporting this week: On Tuesday morning, big biotech Regeneron Pharmaceuticals (REGN) is expected to report earnings of $2.77 a share, up 12% from the year-earlier quarter, according to analysts’ consensus compiled by Thomson Reuters. Sales are estimated to have climbed

IBD 50: 10 Top Stocks Reporting Earnings This Week

Stocks went for a wild ride this past week, with a swath of earnings reports from big names. But the roller coaster of Q2 results isn’t slowing down just yet. Ten top-rated IBD 50 stocks are all geared up to issue their quarterly performances: Allergan (AGN), Regeneron Pharmaceuticals (REGN), Jazz Pharmaceuticals (JAZZ), Monster Beverage (MNST), Gray Television (GTN), Paycom Software (PAYC), Criteo (CRTO), Epam Systems (EPAM), AMC Networks (AMCX),

5 Hot Drug Stocks Top IBD’s Big Cap Leaders Screen

Biotechs, generic-drug makers and ethical-drug makers are some of the highest-ranked industry groups among the 197 that IBD tracks, and with recent view-topping earnings reports, FDA approvals and strategic divestments, they’re proving their strength. Five hot drug stocks lead IBD’s Screen Of The Day, Big Cap Leaders: Gilead Sciences (GILD), Jazz Pharmaceuticals (JAZZ), Allergan (AGN), Regeneron Pharmaceuticals (REGN) and Mallinckrodt (MNK).